InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...
Anti-VEGF treatments have significantly increased the workload in ophthalmology due to rising patient numbers for retinal diseases like nAMD, DME, and RVO. The study observed a 199.6% increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback